دورية أكاديمية
أعرض في EDS

Advance provision of medication for induced abortion: A qualitative study of patient perspectives.

التفاصيل البيبلوغرافية
العنوان: Advance provision of medication for induced abortion: A qualitative study of patient perspectives.
المؤلفون: Fiastro AE; University of Washington, Seattle, WA, United States. Electronic address: afiastro@uw.edu., Young E; University of Washington, Seattle, WA, United States., Jacob-Files E; University of Washington, Seattle, WA, United States., Ruben MR; University of Washington, Seattle, WA, United States., Coeytaux FM; Plan C, Washington, DC, United States., Bennett IM; University of Washington, Seattle, WA, United States., Godfrey EM; University of Washington, Seattle, WA, United States.
المصدر: Contraception [Contraception] 2023 Jul; Vol. 123, pp. 110050. Date of Electronic Publication: 2023 Apr 19.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0234361 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0518 (Electronic) Linking ISSN: 00107824 NLM ISO Abbreviation: Contraception Subsets: MEDLINE
أسماء مطبوعة: Publication: New York : Elsevier
Original Publication: Los Altos, Calif., Geron-X.
مواضيع طبية MeSH: Health Services Accessibility* , Abortion, Induced*, Pregnancy ; Female ; Humans ; Qualitative Research ; Ambulatory Care Facilities ; Washington ; Mifepristone/therapeutic use
مستخلص: Objectives: To examine potential users' perspectives regarding the provision of abortion medications for future use or "advance provision."
Study Design: In this qualitative study, we partnered with an independent reproductive health care clinic in Washington State to conduct semistructured, in-depth interviews with 22 individuals who obtained a medication abortion between August 2021 and January 2022. We asked participants their views on advance provision of abortion medications. Interviews were transcribed and deidentified. Inductive content analysis was used to identify major themes.
Results: Participants in our sample generally reacted positively to the idea of abortion medications for future use. Having pills in advance could improve timeliness and convenience of care and decrease the stigma associated with their use. Participants stressed the importance of adequate information regarding medication use, what to expect, and potential side effects. Most concerns about advance provision related to the safety and efficacy of medication abortion.
Conclusions: This study found that individuals who recently obtained a medication abortion supported the provision of abortion medications for future use.
Implications: Patient-centered educational materials, with adequate information for self-managing pregnancy termination, can be shared at time of prescription. Clinicians have an opportunity to offer these safe and effective medications in advance of need and increase timely access to this essential health care service. User concerns regarding abortion medications for future use should inform clinical innovation and evaluative research of service options.
(Copyright © 2023 Elsevier Inc. All rights reserved.)
معلومات مُعتمدة: TL1 RR025016 United States RR NCRR NIH HHS; UL1 TR002319 United States TR NCATS NIH HHS
فهرسة مساهمة: Keywords: Abortion; Advance provision; Medication abortion; Mifepristone; Patient-centered; Telemedicine
المشرفين على المادة: 320T6RNW1F (Mifepristone)
تواريخ الأحداث: Date Created: 20230421 Date Completed: 20230612 Latest Revision: 20240521
رمز التحديث: 20240522
DOI: 10.1016/j.contraception.2023.110050
PMID: 37085094
قاعدة البيانات: MEDLINE
الوصف
تدمد:1879-0518
DOI:10.1016/j.contraception.2023.110050